| Daniel H Moges, MD | |
|
133 Route 3, Dededo, GU 96929-6911 | |
| (671) 645-5500 | |
| Not Available |
| Full Name | Daniel H Moges |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 12 Years |
| Location | 133 Route 3, Dededo, Guam |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1700238722 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 125069136 (Illinois) | Secondary |
| 208M00000X | Hospitalist | M-2179 (Guam) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Guam Regional Medical City | Dededo, GU | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Guam Healthcare Development Incorporated | 9234351776 | 124 |
News Archive
Treating patients who have chronic hepatitis C and advanced liver disease with long-term pegylated interferon significantly decreased their liver enzymes, viral levels and liver inflammation, but the treatment did not slow or prevent the progression of serious liver disease, a study finds.
Using a new tool designed to measure a woman's willingness to use a microbicide (topical gels designed to prevent the sexual transmission of HIV), researchers at The Miriam Hospital and Brown University found that women who have used protective methods in the past, and those with casual sexual partners were more willing to use a microbicide compared to their peers.
Researchers are targeting a possible new weapon in the fight against malaria, science that could also be applied in the fight against other devastating mosquito-borne illnesses, according to a Vanderbilt study published in PLOS ONE.
Minneapolis-St. Paul Business Journal: UnitedHealth Group's technology consulting subsidiary Ingenix, of Eden Prairie, Minn., has purchased Massachusetts tech firm Picis, a maker of emergency room and intensive care software. "Both companies are deeply involved in the area where health care and information technology meet. Ingenix, which had revenue of $1.8 billion last year, provides consulting and outsourcing to almost 6,000 hospitals.
Aspen Dental announced today that the company will donate $2,300 to the Oral Cancer Foundation as part of its commitment to oral cancer detection and treatment. The amount represents a $5 donation for every Vizilite Plus screening conducted at Aspen Dental offices during Oral, Head, and Neck Cancer Awareness Week (April 12-18, 2010).
› Verified 2 days ago
| Entity Name | Guam Healthcare Development Incorporated |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1326447939 PECOS PAC ID: 9234351776 Enrollment ID: O20150326000266 |
News Archive
Treating patients who have chronic hepatitis C and advanced liver disease with long-term pegylated interferon significantly decreased their liver enzymes, viral levels and liver inflammation, but the treatment did not slow or prevent the progression of serious liver disease, a study finds.
Using a new tool designed to measure a woman's willingness to use a microbicide (topical gels designed to prevent the sexual transmission of HIV), researchers at The Miriam Hospital and Brown University found that women who have used protective methods in the past, and those with casual sexual partners were more willing to use a microbicide compared to their peers.
Researchers are targeting a possible new weapon in the fight against malaria, science that could also be applied in the fight against other devastating mosquito-borne illnesses, according to a Vanderbilt study published in PLOS ONE.
Minneapolis-St. Paul Business Journal: UnitedHealth Group's technology consulting subsidiary Ingenix, of Eden Prairie, Minn., has purchased Massachusetts tech firm Picis, a maker of emergency room and intensive care software. "Both companies are deeply involved in the area where health care and information technology meet. Ingenix, which had revenue of $1.8 billion last year, provides consulting and outsourcing to almost 6,000 hospitals.
Aspen Dental announced today that the company will donate $2,300 to the Oral Cancer Foundation as part of its commitment to oral cancer detection and treatment. The amount represents a $5 donation for every Vizilite Plus screening conducted at Aspen Dental offices during Oral, Head, and Neck Cancer Awareness Week (April 12-18, 2010).
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Daniel H Moges, MD 3001 S King Dr Apt 1002, Chicago, IL 60616-3179 Ph: (202) 751-0039 | Daniel H Moges, MD 133 Route 3, Dededo, GU 96929-6911 Ph: (671) 645-5500 |
News Archive
Treating patients who have chronic hepatitis C and advanced liver disease with long-term pegylated interferon significantly decreased their liver enzymes, viral levels and liver inflammation, but the treatment did not slow or prevent the progression of serious liver disease, a study finds.
Using a new tool designed to measure a woman's willingness to use a microbicide (topical gels designed to prevent the sexual transmission of HIV), researchers at The Miriam Hospital and Brown University found that women who have used protective methods in the past, and those with casual sexual partners were more willing to use a microbicide compared to their peers.
Researchers are targeting a possible new weapon in the fight against malaria, science that could also be applied in the fight against other devastating mosquito-borne illnesses, according to a Vanderbilt study published in PLOS ONE.
Minneapolis-St. Paul Business Journal: UnitedHealth Group's technology consulting subsidiary Ingenix, of Eden Prairie, Minn., has purchased Massachusetts tech firm Picis, a maker of emergency room and intensive care software. "Both companies are deeply involved in the area where health care and information technology meet. Ingenix, which had revenue of $1.8 billion last year, provides consulting and outsourcing to almost 6,000 hospitals.
Aspen Dental announced today that the company will donate $2,300 to the Oral Cancer Foundation as part of its commitment to oral cancer detection and treatment. The amount represents a $5 donation for every Vizilite Plus screening conducted at Aspen Dental offices during Oral, Head, and Neck Cancer Awareness Week (April 12-18, 2010).
› Verified 2 days ago